Coexistence of the Oxazolidinone Resistance-Associated Genes cfr and optrA in Enterococcus faecalis From a Healthy Piglet in Brazil. 2020

Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
Institute of Pharmaceutical Sciences, Federal University of Alagoas, Maceió, Brazil.

Oxazolidinones are one of the most important antimicrobials potentially active against glycopeptide- and β-lactam-resistant Gram-positive pathogens. Linezolid-the first oxazolidinone to be approved for clinical use in 2000 by the US Food and Drug Administration-and the newer molecule in the class, tedizolid, inhibit protein synthesis by suppressing the formation of the 70S ribosomal complex in bacteria. Over the past two decades, transferable oxazolidinone resistance genes, in particular cfr and optrA, have been identified in Firmicutes isolated from healthcare-related infections, livestock, and the environment. Our goals in this study were to investigate the genetic contexts and the transferability of the cfr and optrA genes and examine genomic features, such as antimicrobial resistance genes, plasmid incompatibility types, and CRISPR-Cas defenses of a linezolid-resistant Enterococcus faecalis isolated in feces from a healthy pig during an antimicrobial surveillance program for animal production in Brazil. The cfr gene was found to be integrated into a transposon-like structure of 7,759 nt flanked by IS1216E and capable of excising and circularizing, distinguishing it from known genetic contexts for cfr in Enterococcus spp., while optrA was inserted into an Inc18 broad host-range plasmid of >58 kb. Conjugal transfer of cfr and optrA was shown by filter mating. The coexistence of cfr and optrA in an E. faecalis isolated from a healthy nursery pig highlights the need for monitoring the use of antibiotics in the Brazilian swine production system for controlling spread and proliferation of antibiotic resistance.

UI MeSH Term Description Entries
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013293 Enterococcus faecalis A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic. Streptococcus Group D,Streptococcus faecalis
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D016908 Gram-Positive Bacterial Infections Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections, Gram-Positive,Infections, Gram-Positive Bacterial,Bacterial Infection, Gram-Positive,Bacterial Infections, Gram Positive,Gram Positive Bacterial Infections,Gram-Positive Bacterial Infection,Infection, Gram-Positive Bacterial,Infections, Gram Positive Bacterial
D016984 Enterococcus faecium A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source. Streptococcus faecium
D023303 Oxazolidinones Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents. 1,3-Oxazolidin-2-one,Oxazolidin-2-one,Oxazolidinone,1,3-Oxazolidine-2-one,2-Oxazolidone,2-oxazolidinone,1,3 Oxazolidin 2 one,1,3 Oxazolidine 2 one,2 Oxazolidone,2 oxazolidinone,Oxazolidin 2 one
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
July 2020, International journal of antimicrobial agents,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
July 2023, The Journal of antimicrobial chemotherapy,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
June 2016, The Journal of antimicrobial chemotherapy,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
January 2020, International journal of antimicrobial agents,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
October 2021, The Journal of antimicrobial chemotherapy,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
April 2023, Antibiotics (Basel, Switzerland),
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
December 2016, International journal of antimicrobial agents,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
June 2023, Microbiology spectrum,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
January 2018, Frontiers in microbiology,
Lara M Almeida, and Anthony Gaca, and Paulo M Bispo, and François Lebreton, and Jose T Saavedra, and Rafael A Silva, and Irinaldo D Basílio-Júnior, and Felipe M Zorzi, and Pedro H Filsner, and Andrea M Moreno, and Michael S Gilmore
June 2016, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!